- Details
- Oliver Sartor and Alicia Morgans delve into the complexities of implementing Lutetium-177 in clinical practices, especially amid recent supply chain issues. Dr. Sartor emphasizes the importance of multidisciplinary care and effective communication between medical oncologists and radiation oncologists for successful patient management. He outlines the licensure requirements and safety protocols nec...
|
- Details
- Daniel Lin joins Alicia Morgans in highlighting a guideline-directed practical course on how to use genomics in clinical practice. Dr. Lin was part of the instructional course faculty at the AUA annual meeting. The learning objectives of this course include a discussion on the research studies that led to the approval of genomic testing for prostate cancer, ordering appropriate genomic testing bas...
|
- Details
- Ralph Clayman converses with Jaime Landman about the controversial practice of biopsying renal masses, a topic that has stirred significant debate within the medical community. Dr. Landman elucidates the merits of Biopsy Informed Active Surveillance (BIAS), a departure from the existing renal mass guidelines that he argues are largely culture-based rather than data-driven. Dr. Landman highlights t...
|
- Details
- Jaime Landman and Ralph Clayman discuss advancements in stone disease treatment in urology. Dr. Clayman underscores the underutilized 24-hour urine collection and metabolic evaluation, revealing multiple urinary abnormalities in most patients. Both doctors emphasize dietary optimization as a first-line preventive measure and highlight Mini Sip-It, an app designed to increase fluid intake. They dis...
|
- Details
- Alicia Morgans has a conversation with Oliver Sartor regarding updates to the NCCN guidelines concerning patient selection for Lutetium treatment using PSMA PET scans. According to Dr. Sartor, the VISION trial based its approval of PSMA-617 Lutetium-177 on PSMA 11 gallium 68 in patient selection, but other PET scans are equally effective. The choice between PSMA-11 gallium-68 and DCFPYL F18 scans...
|
- Details
- Alicia Morgans is joined by Seth Lerner and discuss his State-of-the-Art Lecture on Bacillus Calmette–Guérin (BCG) unresponsive disease in non-muscle-invasive bladder cancer. They discuss the FDA’s guidance in terms of clinical trial design in the BCG-unresponsive disease space and recap where the treatment landscape is now and what is on the horizon as far as molecular subtypes and predictive bio...
|
- Details
- Jason Hafron and Katie Murray join Ashley Ross in a conversation on the treatment of unfavorable intermediate-risk prostate cancer and the value of the genomic classifier useful in guiding treatment considerations. Biographies: Jason Hafron, MD, Associate Professor of Urology, The William Beaumont School of Medicine, Oakland University, Director of Robotic Surgery, Beaumont Hospital Royal Oak, Aub...
|
- Details
- Zach Klaassen joins Alicia Morgans in discussing an underestimated topic of mental health and its effects on patients with genitourinary cancers. Drs. Klaassen and Morgans discuss hypothesis-generating population-level data in this landscape and talk through the importance of supporting these patients and using what Dr. Klaassen refers to as clinical intuition and asking follow-up questions when s...
|
- Details
- Neal Shore joins Alicia Morgans to discuss pioneering work on establishing the importance of multidisciplinary teams in the management of urologic oncology patients. This was a plenary presentation at the AUA led by Leonard Gomella and Neal Shore and Michael Cookson as panelists. They discussed the importance of a collaborative approach to optimizing patient care. Drs. Morgans and Shore also highl...
|
- Details
- James Eastham and Stephen Boorjian join Alicia Morgans in a conversation on AUA Guidelines focused on localized prostate cancer. The guidelines provide a framework to have a conversation with a patient about their individual situation involving risk assessment, not only from the cancer standpoint but also from the treatment standpoint. These guidelines provide the framework of what physicians shou...
|
